Literature DB >> 24187363

Managing femoral bone loss in revision total hip replacement: fluted tapered modular stems.

M B Cross1, W G Paprosky.   

Abstract

If a surgeon is faced with altered lesser trochanter anatomy when revising the femoral component in revision total hip replacement, a peri-prosthetic fracture, or Paprosky type IIIb or type IV femoral bone loss, a modular tapered stem offers the advantages of accurately controlling femoral version and length. The splines of the taper allow rotational control, and improve the fit in femoral canals with diaphyseal bone loss. In general, two centimetres of diaphyseal contact is all that is needed to gain stability with modular tapered stems. By allowing the proximal body trial to rotate on a well-fixed distal segment during trial reduction, appropriate anteversion can be obtained in order to improve intra-operative stability, and decrease the dislocation risk. However, modular stems should not be used for all femoral revisions, as implant fracture and corrosion at modular junctions can still occur.

Entities:  

Keywords:  Modular; femoral; fluted; revision; tapered

Mesh:

Year:  2013        PMID: 24187363     DOI: 10.1302/0301-620X.95B11.32763

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  3 in total

Review 1.  Classifications In Brief: The Paprosky Classification of Femoral Bone Loss.

Authors:  David A Ibrahim; Navin D Fernando
Journal:  Clin Orthop Relat Res       Date:  2016-08-02       Impact factor: 4.176

2.  Cementless revision femoral stems application of press-fit principles and clinical outcomes.

Authors:  François Canovas; Sophie Putman; Louis Dagneaux; Lamine Chadli; Pierre Le Béguec
Journal:  Int Orthop       Date:  2018-12-15       Impact factor: 3.075

3.  A Case of Cementless Impaction Bone Graft in a Revision Total Hip Arthroplasty Requiring Calcar Reconstruction.

Authors:  Shigeo Ishiguro; Kunihiro Asanuma; Tatsuya Tamaki; Kazuhiro Oinuma; Akihiro Sudo
Journal:  Case Rep Orthop       Date:  2021-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.